GlassScriptPhysician profile
Daniel B Luckenbill
NPI 1154765980
$16,862.85
in general payments reported to CMS, 2019-2025
8 companies · $1,516 in 2025
The $1,516 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,902 · 2020: $2,156 · 2021: $2,400 · 2022: $2,400 · 2023: $196 · 2024: $1,293 · 2025: $1,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,200 · Travel and Lodging: $1,191 · Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,200.00 |
| Travel and Lodging | $1,191.42 |
| Food and Beverage | $613.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cdc Medical LLC | $8,038.90 | 2019-2022 | |
| Arthrex, INC. | $5,636.26 | 2019-2025 | |
| Joint Restoration Foundation, INC. | $1,200.00 | 2024 | |
| Legacy Ortho LLC | $919.25 | 2025 | |
| Medical Device Business Services, INC. | $679.23 | 2019 | |
| Nuvasive, INC. | $196.45 | 2023 | Pulse |
| Vericel Corporation | $100.00 | 2019 | |
| Community Blood Center | $92.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Luckenbill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.